相似文献
1
Lung Cancer through Transcription Factors.
Int J Mol Sci. 2023 May 30;24(11):9461. doi: 10.3390/ijms24119461.
2
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
Lung Cancer. 2018 Nov;125:282-290. doi: 10.1016/j.lungcan.2018.10.006. Epub 2018 Oct 9.
3
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
Clin Cancer Res. 2016 Jul 15;22(14):3618-29. doi: 10.1158/1078-0432.CCR-15-2946. Epub 2016 Mar 9.
4
[DDP-sensitivity-related genes in 10 lung cancer cell lines].
Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):418-21.
5
MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
J Exp Clin Cancer Res. 2010 Jun 17;29(1):75. doi: 10.1186/1756-9966-29-75.
6
Survivin expression impacts prognostically on NSCLC but not SCLC.
Lung Cancer. 2013 Feb;79(2):180-6. doi: 10.1016/j.lungcan.2012.11.004. Epub 2012 Dec 4.
7
MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
Cancer Discov. 2014 Mar;4(3):292-303. doi: 10.1158/2159-8290.CD-13-0799. Epub 2013 Dec 20.
8
Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
Cytogenet Genome Res. 2017;152(3):122-131. doi: 10.1159/000479809. Epub 2017 Sep 13.
9
Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Mol Oncol. 2020 Feb;14(2):277-293. doi: 10.1002/1878-0261.12608. Epub 2019 Dec 15.
10
Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
J Cancer Res Clin Oncol. 2016 May;142(5):981-93. doi: 10.1007/s00432-016-2117-4. Epub 2016 Feb 2.
引用本文的文献
1
The Interplay Between Oxidant/Antioxidant System, Transcription Factors, and Non-Coding RNA in Lung Cancer.
Int J Mol Sci. 2025 Aug 8;26(16):7679. doi: 10.3390/ijms26167679.
2
TFAP2A upregulates FAM83A to suppress ferroptosis and diminish cisplatin sensitivity in non-small cell lung cancer.
Cell Div. 2025 Jul 11;20(1):19. doi: 10.1186/s13008-025-00162-0.
3
NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker.
Cancer Sci. 2025 Sep;116(9):2400-2412. doi: 10.1111/cas.70122. Epub 2025 Jul 10.
本文引用的文献
1
TTF-1 and immune checkpoint therapy in non-small cell lung cancer.
Transl Lung Cancer Res. 2023 Mar 31;12(3):398-400. doi: 10.21037/tlcr-23-101. Epub 2023 Mar 24.
2
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment.
Natl Sci Rev. 2023 Feb 14;10(4):nwad028. doi: 10.1093/nsr/nwad028. eCollection 2023 Apr.
3
Tackling the "Bottleneck" of Non-Small Cell Lung Cancer Pathobiology.
Arch Med Res. 2023 Jun;54(4):350-351. doi: 10.1016/j.arcmed.2023.03.007. Epub 2023 Apr 5.
4
Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC).
Cells. 2023 Mar 10;12(6):871. doi: 10.3390/cells12060871.
5
Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC.
Cancers (Basel). 2023 Jan 6;15(2):386. doi: 10.3390/cancers15020386.
6
Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer.
Curr Issues Mol Biol. 2023 Jan 5;45(1):434-464. doi: 10.3390/cimb45010029.
7
Targeting PEA3 transcription factors to mitigate small cell lung cancer progression.
Oncogene. 2023 Feb;42(6):434-448. doi: 10.1038/s41388-022-02558-6. Epub 2022 Dec 13.
8
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.
Cell Commun Signal. 2022 Sep 19;20(1):147. doi: 10.1186/s12964-022-00946-9.
9
BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors.
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI133090.
10
Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma.
Oncogenesis. 2020 Oct 17;9(10):92. doi: 10.1038/s41389-020-00277-9.
Zotero 插件